Skip to main content
Erschienen in: Inflammation 3/2018

18.01.2018 | ORIGINAL ARTICLE

Plantamajoside Inhibits Lipopolysaccharide-Induced MUC5AC Expression and Inflammation through Suppressing the PI3K/Akt and NF-κB Signaling Pathways in Human Airway Epithelial Cells

verfasst von: Chaonan Ma, Wei Ma

Erschienen in: Inflammation | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

It has been reported that plantamajoside (PMS), a major natural compound isolated from Plantago asiatica, has anti-inflammatory activities. However, the effect of PMS on respiratory inflammatory diseases has not yet been studied. The present study aimed to evaluate the effect of PMS on lipopolysaccharide (LPS)-induced airway inflammation and the underlying mechanism. The results showed that PMS did not affect the cell viability of 16-HBE cells. PMS (20 and 40 μg/ml) decreased the expression levels of MUC5AC, IL-6, and IL-1β, which were induced by LPS treatment. PMS inhibited the LPS-induced phosphorylation of Akt and p65. In addition, inhibitors of the PI3K/Akt and NF-κB pathways attenuated the effect of LPS on 16-HBE cells. In conclusion, PMS inhibits LPS-induced MUC5AC expression and inflammation through suppressing the PI3K/Akt and NF-κB signaling pathways, indicating that PMS may be a potential therapy for the treatment of respiratory inflammatory diseases.
Literatur
1.
Zurück zum Zitat Samuelsen, A.B. 2000. The traditional uses, chemical constituents and biological activities of Plantago major L. a review. Journal of Ethnopharmacology 71: 1–21.CrossRefPubMed Samuelsen, A.B. 2000. The traditional uses, chemical constituents and biological activities of Plantago major L. a review. Journal of Ethnopharmacology 71: 1–21.CrossRefPubMed
2.
Zurück zum Zitat Huang, D.F., Y.F. Tang, S.P. Nie, Y. Wan, M.Y. Xie, and X.M. Xie. 2009. Effect of phenylethanoid glycosides and polysaccharides from the seed of Plantago asiatica L. on the maturation of murine bone marrow-derived dendritic cells. European Journal of Pharmacology 620: 105–111.CrossRefPubMed Huang, D.F., Y.F. Tang, S.P. Nie, Y. Wan, M.Y. Xie, and X.M. Xie. 2009. Effect of phenylethanoid glycosides and polysaccharides from the seed of Plantago asiatica L. on the maturation of murine bone marrow-derived dendritic cells. European Journal of Pharmacology 620: 105–111.CrossRefPubMed
3.
Zurück zum Zitat Wu, H., G. Zhao, K. Jiang, X. Chen, Z. Zhu, C. Qiu, C. Li, and G. Deng. 2016. Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation. International Immunopharmacology 35: 315–322.CrossRefPubMed Wu, H., G. Zhao, K. Jiang, X. Chen, Z. Zhu, C. Qiu, C. Li, and G. Deng. 2016. Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation. International Immunopharmacology 35: 315–322.CrossRefPubMed
4.
Zurück zum Zitat Pei, S., X. Yang, H. Wang, H. Zhang, B. Zhou, D. Zhang, and D. Lin. 2015. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer 15 (965). Pei, S., X. Yang, H. Wang, H. Zhang, B. Zhou, D. Zhang, and D. Lin. 2015. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer 15 (965).
5.
Zurück zum Zitat Katial, R.K., G.W. Bensch, W.W. Busse, B.E. Chipps, J.L. Denson, A.N. Gerber, J.S. Jacobs, M. Kraft, R.J. Martin, P. Nair, and M.E. Wechsler. 2017. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. The Journal of Allergy and Clinical Immunology. In Practice 5: S1–S14.CrossRefPubMed Katial, R.K., G.W. Bensch, W.W. Busse, B.E. Chipps, J.L. Denson, A.N. Gerber, J.S. Jacobs, M. Kraft, R.J. Martin, P. Nair, and M.E. Wechsler. 2017. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. The Journal of Allergy and Clinical Immunology. In Practice 5: S1–S14.CrossRefPubMed
6.
Zurück zum Zitat Perng, D.W., and P.K. Chen. 2017. The relationship between airway inflammation and exacerbation in chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul) 80: 325–335.CrossRef Perng, D.W., and P.K. Chen. 2017. The relationship between airway inflammation and exacerbation in chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul) 80: 325–335.CrossRef
7.
Zurück zum Zitat Eapen, M.S., S. Myers, E.H. Walters, and S.S. Sohal. 2017. Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox. Expert Review of Respiratory Medicine 11: 827–839.CrossRefPubMed Eapen, M.S., S. Myers, E.H. Walters, and S.S. Sohal. 2017. Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox. Expert Review of Respiratory Medicine 11: 827–839.CrossRefPubMed
8.
Zurück zum Zitat Malaviya, R., J.D. Laskin, and D.L. Laskin. 2017. Anti-TNFα therapy in inflammatory lung diseases. Pharmacology & Therapeutics 180: 90–98.CrossRef Malaviya, R., J.D. Laskin, and D.L. Laskin. 2017. Anti-TNFα therapy in inflammatory lung diseases. Pharmacology & Therapeutics 180: 90–98.CrossRef
9.
Zurück zum Zitat Dong, S.J., Y.Q. Zhong, W.T. Lu, G.H. Li, H.L. Jiang, and B. Mao. 2015. Baicalin inhibits lipopolysaccharide-induced inflammation through signaling NF-κB pathway in HBE16 airway epithelial cells. Inflammation 38: 1493–1501.CrossRefPubMed Dong, S.J., Y.Q. Zhong, W.T. Lu, G.H. Li, H.L. Jiang, and B. Mao. 2015. Baicalin inhibits lipopolysaccharide-induced inflammation through signaling NF-κB pathway in HBE16 airway epithelial cells. Inflammation 38: 1493–1501.CrossRefPubMed
10.
Zurück zum Zitat Lee, I.T., and C.M. Yang. 2013. Inflammatory signalings involved in airway and pulmonary diseases. Mediators of Inflammation 2013 (791231). Lee, I.T., and C.M. Yang. 2013. Inflammatory signalings involved in airway and pulmonary diseases. Mediators of Inflammation 2013 (791231).
11.
Zurück zum Zitat Medina-Tato, D.A., S.G. Ward, and M.L. Watson. 2007. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology 121: 448–461.CrossRefPubMedPubMedCentral Medina-Tato, D.A., S.G. Ward, and M.L. Watson. 2007. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology 121: 448–461.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lee, K.S., H.K. Lee, J.S. Hayflick, Y.C. Lee, and K.D. Puri. 2006. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. The FASEB Journal 20: 455–465.CrossRefPubMed Lee, K.S., H.K. Lee, J.S. Hayflick, Y.C. Lee, and K.D. Puri. 2006. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. The FASEB Journal 20: 455–465.CrossRefPubMed
13.
Zurück zum Zitat Song, K.S., J.H. Yoon, K.S. Kim, and D.W. Ahn. 2012. c-Ets1 inhibits the interaction of NF-κB and CREB, and downregulates IL-1β-induced MUC5AC overproduction during airway inflammation. Mucosal Immunology 5: 207–215.CrossRefPubMedPubMedCentral Song, K.S., J.H. Yoon, K.S. Kim, and D.W. Ahn. 2012. c-Ets1 inhibits the interaction of NF-κB and CREB, and downregulates IL-1β-induced MUC5AC overproduction during airway inflammation. Mucosal Immunology 5: 207–215.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Solanki, P., A. Aminoshariae, G. Jin, T.A. Montagnese, and A. Mickel. 2013. The effect of docosahexaenoic acid (DHA) on expression of IL-1ss, IL-6, IL-8, and TNF-α in normal and lipopolysaccharide (LPS)-stimulated macrophages. Quintessence International 44: 393.PubMed Solanki, P., A. Aminoshariae, G. Jin, T.A. Montagnese, and A. Mickel. 2013. The effect of docosahexaenoic acid (DHA) on expression of IL-1ss, IL-6, IL-8, and TNF-α in normal and lipopolysaccharide (LPS)-stimulated macrophages. Quintessence International 44: 393.PubMed
15.
Zurück zum Zitat Schonknecht, K., H. Krauss, J. Jambor, and A.M. Fal. 2016. Treatment of cough in respiratory tract infections—the effect of combining the natural active compounds with thymol. Wiadomości Lekarskie 69: 791–798.PubMed Schonknecht, K., H. Krauss, J. Jambor, and A.M. Fal. 2016. Treatment of cough in respiratory tract infections—the effect of combining the natural active compounds with thymol. Wiadomości Lekarskie 69: 791–798.PubMed
16.
Zurück zum Zitat Ayrle, H., M. Mevissen, M. Kaske, H. Nathues, N. Gruetzner, M. Melzig, and M. Walkenhorst. 2016. Medicinal plants-prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review. BMC Veterinary Research 12 (89). Ayrle, H., M. Mevissen, M. Kaske, H. Nathues, N. Gruetzner, M. Melzig, and M. Walkenhorst. 2016. Medicinal plants-prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review. BMC Veterinary Research 12 (89).
17.
Zurück zum Zitat Komoda, Y., H. Chujo, S. Ishihara, and M. Uchida. 1989. HPLC quantitative analysis of plantaginin in Shazenso (Plantago asiatica L.) extracts and isolation of plantamajoside. Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku 23: 81–85.PubMed Komoda, Y., H. Chujo, S. Ishihara, and M. Uchida. 1989. HPLC quantitative analysis of plantaginin in Shazenso (Plantago asiatica L.) extracts and isolation of plantamajoside. Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku 23: 81–85.PubMed
18.
Zurück zum Zitat Son, W.R., M.H. Nam, C.O. Hong, Y. Kim, and K.W. Lee. 2017. Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-κB. BMC Complementary and Alternative Medicine 17 (66). Son, W.R., M.H. Nam, C.O. Hong, Y. Kim, and K.W. Lee. 2017. Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-κB. BMC Complementary and Alternative Medicine 17 (66).
19.
Zurück zum Zitat De Dooy, J.J., L.M. Mahieu, and H.P. Van Bever. 2001. The role of inflammation in the development of chronic lung disease in neonates. European Journal of Pediatrics 160: 457–463.CrossRefPubMed De Dooy, J.J., L.M. Mahieu, and H.P. Van Bever. 2001. The role of inflammation in the development of chronic lung disease in neonates. European Journal of Pediatrics 160: 457–463.CrossRefPubMed
20.
Zurück zum Zitat Entrican, G., S. Wattegedera, M. Rocchi, D.C. Fleming, R.W. Kelly, G. Wathne, V. Magdalenic, and S.E. Howie. 2004. Induction of inflammatory host immune responses by organisms belonging to the genera Chlamydia/Chlamydophila. Veterinary Immunology and Immunopathology 100: 179–186.CrossRefPubMed Entrican, G., S. Wattegedera, M. Rocchi, D.C. Fleming, R.W. Kelly, G. Wathne, V. Magdalenic, and S.E. Howie. 2004. Induction of inflammatory host immune responses by organisms belonging to the genera Chlamydia/Chlamydophila. Veterinary Immunology and Immunopathology 100: 179–186.CrossRefPubMed
21.
Zurück zum Zitat Na, H.G., C.H. Bae, Y.S. Choi, S.Y. Song, and Y.D. Kim. 2016. Spleen tyrosine kinase induces MUC5AC expression in human airway epithelial cell. American Journal of Rhinology & Allergy 30: 89–93.CrossRef Na, H.G., C.H. Bae, Y.S. Choi, S.Y. Song, and Y.D. Kim. 2016. Spleen tyrosine kinase induces MUC5AC expression in human airway epithelial cell. American Journal of Rhinology & Allergy 30: 89–93.CrossRef
22.
Zurück zum Zitat Haegens, A., T.F. Barrett, J. Gell, A. Shukla, M. Macpherson, P. Vacek, M.E. Poynter, K.J. Butnor, Y.M. Janssen-Heininger, C. Steele, and B.T. Mossman. 2007. Airway epithelial NF-κB activation modulates asbestos-induced inflammation and mucin production in vivo. Journal of Immunology 178: 1800–1808.CrossRef Haegens, A., T.F. Barrett, J. Gell, A. Shukla, M. Macpherson, P. Vacek, M.E. Poynter, K.J. Butnor, Y.M. Janssen-Heininger, C. Steele, and B.T. Mossman. 2007. Airway epithelial NF-κB activation modulates asbestos-induced inflammation and mucin production in vivo. Journal of Immunology 178: 1800–1808.CrossRef
23.
Zurück zum Zitat Kim, H.J., S.H. Park, S.Y. Park, U.Y. Moon, B.D. Lee, S.H. Yoon, J.G. Lee, S.J. Baek, and J.H. Yoon. 2008. Epigallocatechin-3-gallate inhibits interleukin-1β-induced MUC5AC gene expression and MUC5AC secretion in normal human nasal epithelial cells. The Journal of Nutritional Biochemistry 19: 536–544.CrossRefPubMed Kim, H.J., S.H. Park, S.Y. Park, U.Y. Moon, B.D. Lee, S.H. Yoon, J.G. Lee, S.J. Baek, and J.H. Yoon. 2008. Epigallocatechin-3-gallate inhibits interleukin-1β-induced MUC5AC gene expression and MUC5AC secretion in normal human nasal epithelial cells. The Journal of Nutritional Biochemistry 19: 536–544.CrossRefPubMed
24.
Zurück zum Zitat Kim, C.H., K.S. Song, J.S. Koo, H.U. Kim, J.Y. Cho, H.J. Kim, and J.H. Yoon. 2002. IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells. Acta Oto-Laryngologica 122: 638–643.CrossRefPubMed Kim, C.H., K.S. Song, J.S. Koo, H.U. Kim, J.Y. Cho, H.J. Kim, and J.H. Yoon. 2002. IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells. Acta Oto-Laryngologica 122: 638–643.CrossRefPubMed
25.
Zurück zum Zitat Choi, Y.H., G.Y. Jin, L.C. Li, and G.H. Yan. 2013. Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1α/VEGF pathway. PLoS One 8: e81773.CrossRefPubMedPubMedCentral Choi, Y.H., G.Y. Jin, L.C. Li, and G.H. Yan. 2013. Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1α/VEGF pathway. PLoS One 8: e81773.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Chen, L., J. Chen, C.M. Xie, Y. Zhao, X. Wang, and Y.H. Zhang. 2015. Maternal disononyl phthalate exposure activates allergic airway inflammation via stimulating the phosphoinositide 3-kinase/Akt pathway in rat pups. Biomedical and Environmental Sciences 28: 190–198.PubMed Chen, L., J. Chen, C.M. Xie, Y. Zhao, X. Wang, and Y.H. Zhang. 2015. Maternal disononyl phthalate exposure activates allergic airway inflammation via stimulating the phosphoinositide 3-kinase/Akt pathway in rat pups. Biomedical and Environmental Sciences 28: 190–198.PubMed
27.
Zurück zum Zitat Mishra, V., V. Baranwal, R.K. Mishra, S. Sharma, B. Paul, and A.C. Pandey. 2016. Titanium dioxide nanoparticles augment allergic airway inflammation and Socs3 expression via NF-κB pathway in murine model of asthma. Biomaterials 92: 90–102.CrossRefPubMed Mishra, V., V. Baranwal, R.K. Mishra, S. Sharma, B. Paul, and A.C. Pandey. 2016. Titanium dioxide nanoparticles augment allergic airway inflammation and Socs3 expression via NF-κB pathway in murine model of asthma. Biomaterials 92: 90–102.CrossRefPubMed
28.
Zurück zum Zitat Bui, T.T., C.H. Piao, S.M. Kim, C.H. Song, H.S. Shin, C.H. Lee, and O.H. Chai. 2017. Citrus tachibana leaves ethanol extract alleviates airway inflammation by the modulation of Th1/Th2 imbalance via inhibiting NF-κB signaling and histamine secretion in a mouse model of allergic asthma. Journal of Medicinal Food 20: 676–684.CrossRefPubMed Bui, T.T., C.H. Piao, S.M. Kim, C.H. Song, H.S. Shin, C.H. Lee, and O.H. Chai. 2017. Citrus tachibana leaves ethanol extract alleviates airway inflammation by the modulation of Th1/Th2 imbalance via inhibiting NF-κB signaling and histamine secretion in a mouse model of allergic asthma. Journal of Medicinal Food 20: 676–684.CrossRefPubMed
Metadaten
Titel
Plantamajoside Inhibits Lipopolysaccharide-Induced MUC5AC Expression and Inflammation through Suppressing the PI3K/Akt and NF-κB Signaling Pathways in Human Airway Epithelial Cells
verfasst von
Chaonan Ma
Wei Ma
Publikationsdatum
18.01.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0733-7

Weitere Artikel der Ausgabe 3/2018

Inflammation 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.